標題: Titlebook: Basic Science of PET Imaging; Magdy M. Khalil Book 2017 Springer International Publishing Switzerland 2017 Hybrid Imaging.Molecular Imagin [打印本頁] 作者: 尤指植物 時間: 2025-3-21 16:09
書目名稱Basic Science of PET Imaging影響因子(影響力)
書目名稱Basic Science of PET Imaging影響因子(影響力)學科排名
書目名稱Basic Science of PET Imaging網(wǎng)絡公開度
書目名稱Basic Science of PET Imaging網(wǎng)絡公開度學科排名
書目名稱Basic Science of PET Imaging被引頻次
書目名稱Basic Science of PET Imaging被引頻次學科排名
書目名稱Basic Science of PET Imaging年度引用
書目名稱Basic Science of PET Imaging年度引用學科排名
書目名稱Basic Science of PET Imaging讀者反饋
書目名稱Basic Science of PET Imaging讀者反饋學科排名
作者: 弄皺 時間: 2025-3-21 20:22 作者: Infant 時間: 2025-3-22 00:41
Radiation Dosimetry of PET Imaginguman studies. Animal data extrapolation and data analysis for human imaging data are given by example. Dose quantities are explained and, again, given by example. Standardized doses, for general cases and for the pregnant or lactating female, are given.作者: VEST 時間: 2025-3-22 05:29
Chemistry of PET Radiopharmaceuticals: Labelling Strategieses to image and measure biochemical processes of mammalian biology in vivo. Since this area is rapidly developing, the demand for rapid synthetic methods for radiolabelling the molecule of interest is one of the main challenges for the radiochemists. This chapter will provide information about the m作者: EVADE 時間: 2025-3-22 10:28 作者: stressors 時間: 2025-3-22 16:07
Regulation of PET Radiopharmaceuticals Production in Europe from a regulatory point of view as both pharmaceutical good manufacturing practice (GMP) and radiation safety aspects have to be balanced against each other. As a consequence of this, the production of PET radiopharmaceuticals must comply with both GMP and local radiation safety rules. This chapter作者: justify 時間: 2025-3-22 19:06
Regulatory Aspects of PET Radiopharmaceutical Production in the United States (CGMP) requirements for positron emission tomography (PET) drugs. As directed by the US Congress in the Modernization Act, the costly CGMP regulations which the FDA applies to large pharmaceutical manufacturers are not appropriate for the PET drugs due to the unique properties of these drugs mainly作者: 泰然自若 時間: 2025-3-22 22:28 作者: 松雞 時間: 2025-3-23 03:11
PET/MR: Basics and New Developmentsecades. This has impacted significantly many aspects of patient diagnosis, stratification, prognosis, and treatment strategies. After the advent of SPECT/CT and PET/CT to the clinical arena, PET/MR was introduced shortly afterward with real simultaneous capabilities and additional features mainly ch作者: Allege 時間: 2025-3-23 09:17 作者: barium-study 時間: 2025-3-23 10:01 作者: CURT 時間: 2025-3-23 14:56
Image Processing and Analysis of PET and Hybrid PET Imagingdisease progression, identification of the treatment gross tumor volume, monitoring of disease, as well as prediction of outcomes and personalization of treatment regimens. Among the arsenal of different functional imaging modalities, PET has benefited from early adoption of quantitative image analy作者: FLOUR 時間: 2025-3-23 21:04 作者: 價值在貶值 時間: 2025-3-24 01:46 作者: 禁止 時間: 2025-3-24 03:10 作者: hankering 時間: 2025-3-24 08:54 作者: CORD 時間: 2025-3-24 11:08 作者: Seizure 時間: 2025-3-24 18:00
osimetry.Covers the basics of and developments in various PE.This book offers a wide-ranging and up-to-date overview of the basic science underlying PET and. its preclinical and clinical applications in modern medicine. In addition, it provides the reader with a sound understanding of the scientific作者: 杠桿支點 時間: 2025-3-24 20:16
https://doi.org/10.1007/1-4020-2156-9tistical reconstruction methods. We also briefly describe data corrections necessary for PET image reconstruction, which are important for reducing artifacts and improving quantitative accuracy. Finally some recent developments are described, including the reconstruction of time-of-flight (TOF) PET data and direct parametric image reconstruction.作者: 倫理學 時間: 2025-3-25 01:42
PET Image Reconstruction: Methodology and Quantitative Accuracytistical reconstruction methods. We also briefly describe data corrections necessary for PET image reconstruction, which are important for reducing artifacts and improving quantitative accuracy. Finally some recent developments are described, including the reconstruction of time-of-flight (TOF) PET data and direct parametric image reconstruction.作者: 表否定 時間: 2025-3-25 05:36 作者: 營養(yǎng) 時間: 2025-3-25 10:55
Compartmental Modeling in PET Kineticspproaches for fast estimation of the kinetic parameters are introduced based on general compartmental model. The input function for the compartmental model is important for quantitative analysis of PET data, and the reference region model is one approach to avoid acquisition of the input function.作者: Aspirin 時間: 2025-3-25 14:54 作者: grounded 時間: 2025-3-25 18:02
Basic Radiation Physicsts as well as mostly commonly used radiation detection and measurement devices. As this is the first chapter in the book, we made every effort to cover as many aspects that might come across the reader throughout or facilitate the understanding of other chapters.作者: Solace 時間: 2025-3-25 22:02 作者: 不可思議 時間: 2025-3-26 04:03
HDL in Infectious Diseases and Sepsisl techniques and the validation of analytical methods commonly employed in the quality control testing of PET radiopharmaceuticals are reported. Specific sections about the quality control of .F, .C, and .Ga radiopharmaceuticals according to EP monographs are also provided as example for the routine testing of these preparations.作者: Debark 時間: 2025-3-26 04:17 作者: 鞏固 時間: 2025-3-26 12:19
Quality Control of PET Radiopharmaceuticalsl techniques and the validation of analytical methods commonly employed in the quality control testing of PET radiopharmaceuticals are reported. Specific sections about the quality control of .F, .C, and .Ga radiopharmaceuticals according to EP monographs are also provided as example for the routine testing of these preparations.作者: 多產(chǎn)子 時間: 2025-3-26 16:13
HDL in Infectious Diseases and Sepsist Dossier is described, also an approach to minimise the very costly toxicological studies. The essentials of GMP and quality management systems are explained. The chapter ends with some future directions and convenient GMP approaches.作者: 放肆的你 時間: 2025-3-26 19:47
https://doi.org/10.1007/978-3-319-09665-0o provides a more flexible regulatory framework for investigational PET drugs for human use produced under an investigational new drug application (IND) in accordance with part 312 and PET drugs produced with the approval of a Radioactive Drug Research Committee (RDRC) in accordance with part 361. T作者: 膠狀 時間: 2025-3-26 21:59
https://doi.org/10.1007/978-1-4419-1059-2, ending with a brief discussion on the outlook and future directions for PET instrumentation research. This chapter highlights recent advances in PET instrumentation and describes their impact and contribution to the improvement in clinical PET imaging.作者: chemoprevention 時間: 2025-3-27 01:30 作者: Exclude 時間: 2025-3-27 09:18 作者: 前面 時間: 2025-3-27 10:20 作者: 空中 時間: 2025-3-27 15:31
Preparation of High Dilutions of Drugs,imple to calculate showing effectiveness in a number of malignancies, is prone to many technical and biological errors if not properly adjusted. All of the above have been reviewed in this chapter along with other new emerging volumetric and disease burden quantitative metrics.作者: 虛度 時間: 2025-3-27 19:12
Book 2017nstruction, processing, and quantitation in PET and hybrid PET and on imaging artifacts and correction techniques, with particular attention to partial volume correction and motion artifacts.. .The book closes by examining clinical applications of PET and hybrid PET and their physiological and/or mo作者: 帶傷害 時間: 2025-3-28 01:17 作者: fatty-streak 時間: 2025-3-28 03:40 作者: 才能 時間: 2025-3-28 06:50 作者: 導師 時間: 2025-3-28 13:16
PET/MR: Basics and New Developmentslogy was one of the reasons beyond the success of hybrid PET/MR. Thus, some details were provided for different types of crystals and light photosensors along with other interfering variables with MR detector components. Attenuation and motion correction in PET/MR imaging were reviewed with recent t作者: 泥沼 時間: 2025-3-28 15:26 作者: 有常識 時間: 2025-3-28 20:42
Image Processing and Analysis of PET and Hybrid PET Imagingentation/registration and more recent image-based outcome modeling in the radiomics field. We further extend the discussion into hybrid anatomical functional combinations of PET/CT and PET/MR multimodalities.作者: 皺痕 時間: 2025-3-29 01:29
Basics and Advances of Quantitative PET Imagingimple to calculate showing effectiveness in a number of malignancies, is prone to many technical and biological errors if not properly adjusted. All of the above have been reviewed in this chapter along with other new emerging volumetric and disease burden quantitative metrics.作者: grudging 時間: 2025-3-29 05:10 作者: PALL 時間: 2025-3-29 09:41 作者: ORE 時間: 2025-3-29 11:44
Magnetic Heads For High Density Recording,edicine departments. Facility design and shielding calculations are described and examples given. Challenges in keeping doses to the staff and public down are described with some of the approaches to keeping doses as low as reasonably achievable. Computed tomography (CT) technology and dose metrics 作者: 舊病復發(fā) 時間: 2025-3-29 16:07 作者: cipher 時間: 2025-3-29 23:42 作者: effrontery 時間: 2025-3-29 23:55
HDL in Infectious Diseases and Sepsisese radiopharmaceuticals is important to assure the safety of the product before the release for clinical use. For this reason, efficient and quick tests have been adopted to check the quality of radiopharmaceutical preparations and specific procedures have been published in each country or regions 作者: Arroyo 時間: 2025-3-30 08:00
HDL in Infectious Diseases and Sepsis from a regulatory point of view as both pharmaceutical good manufacturing practice (GMP) and radiation safety aspects have to be balanced against each other. As a consequence of this, the production of PET radiopharmaceuticals must comply with both GMP and local radiation safety rules. This chapter作者: 繞著哥哥問 時間: 2025-3-30 10:48
https://doi.org/10.1007/978-3-319-09665-0 (CGMP) requirements for positron emission tomography (PET) drugs. As directed by the US Congress in the Modernization Act, the costly CGMP regulations which the FDA applies to large pharmaceutical manufacturers are not appropriate for the PET drugs due to the unique properties of these drugs mainly作者: FIR 時間: 2025-3-30 16:13 作者: Minikin 時間: 2025-3-30 19:24
